Mario Giuliano
Overview
Explore the profile of Mario Giuliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
2785
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berton Giachetti P, Morganti S, Gandini S, Giudici F, Marra A, Nicolo E, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2461067.
PMID: 39982725
Importance: Endocrine therapy (ET) combined with cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) agents is the standard first-line treatment for patients with hormone receptor-positive, ERBB2 (formerly HER2 or HER2/neu)-negative metastatic breast cancer....
2.
Caltavituro A, Buonaiuto R, Salomone F, Pecoraro G, Martorana F, Lauro V, et al.
Crit Rev Oncol Hematol
. 2024 Nov;
206:104577.
PMID: 39613237
The advent of immune checkpoint inhibitors (ICIs) has deeply reshaped the therapeutic algorithm of triple-negative breast cancer (TNBC). However, there is considerable scope for better engagement of the immune system...
3.
Buonaiuto R, Caltavituro A, Tafuro M, Longobardi A, Pavone G, De Santis P, et al.
Breast
. 2024 Nov;
79:103833.
PMID: 39579620
Background: The combination of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) with endocrine therapy (ET) is the standard of care for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative...
4.
Cioffi I, Di Vincenzo O, Morlino D, da Silva B, Prado C, Santarpia L, et al.
Clin Nutr
. 2024 Sep;
43(11):54-64.
PMID: 39342800
Background & Aims: Breast cancer (BC) is frequently linked with obesity, metabolic syndrome, and sarcopenia. Therefore, measuring or accurately estimating resting energy expenditure (REE) is crucial for tailoring nutritional needs,...
5.
Peddio A, Pietroluongo E, Lamia M, Luciano A, Caltavituro A, Buonaiuto R, et al.
Crit Rev Oncol Hematol
. 2024 Sep;
204:104524.
PMID: 39326646
Neuroendocrine neoplasms (NENs) represent a diagnostic and therapeutic challenge, due to their heterogeneity and limited treatment options. Conventional imaging techniques and therapeutic strategies may become unreliable during follow-up, due to...
6.
Buonaiuto R, Neola G, Caltavituro A, Longobardi A, Mangiacotti F, Cefaliello A, et al.
Front Oncol
. 2024 Sep;
14:1412807.
PMID: 39314634
Objective: Preclinical studies have emphasized the potential connection between BRCA specific domains defects and the activity of Poly ADP-ribose polymerase inhibitors (PARPi). Nevertheless, real-world evidence regarding the impact of BRCA...
7.
Ahmadi-Hadad A, de Queiroz P, Schettini F, Giuliano M
Crit Rev Oncol Hematol
. 2024 Sep;
204:104516.
PMID: 39306311
Triple-negative breast cancer (TNBC) exhibits a proclivity for early recurrence and development of metastasis. Moreover, drug resistance tends to arise few months following chemotherapeutic regimen with agents such as Doxorubicin,...
8.
Di Grazia G, Conti C, Nucera S, Motta G, Martorana F, Stella S, et al.
Front Oncol
. 2024 Aug;
14:1427228.
PMID: 39211557
The REarranged during Transfection (RET) receptor tyrosine kinase plays a crucial role in the development of various anatomical structures during embryogenesis and it is involved in many physiological cellular processes....
9.
Pietroluongo E, Luciano A, Peddio A, Buonaiuto R, Caltavituro A, Servetto A, et al.
J Med Virol
. 2024 Aug;
96(8):e29849.
PMID: 39135451
Kaposi's sarcoma (KS) is an angio-proliferative disease with a viral etiology and a multifactorial pathogenesis that results from immune dysfunction. In patients affected by latent viral infections such as herpesviruses,...
10.
Nardi E, Santoro C, Prastaro M, Canonico M, Paolillo S, Gargiulo G, et al.
Cardiooncology
. 2024 Aug;
10(1):48.
PMID: 39113118
Atrial fibrillation (AF) is more common in patients with malignancies than in general population. The pathophysiological processes include the pro-inflammatory condition and the exaggerated inflammatory reaction to chemotherapy, radiotherapy, and...